GLO1 and melanoma: First, A375 human malignant melanoma cells with GLO1 deletion (A375-GLO1-KO) were engineered using CRISPR/Cas9, and genetic rescue clones were generated by stable transfection of KO clones employing a CMV-driven GLO1 construct (A375-GLO1-R) (Figure 1).